Enzyme replacement therapy for fabry disease, an inherited nephropathy

Keyphrases

• Acroparesthesia 33%
• Adulthood 33%
• Angiokeratoma 33%
• Cardiac Variant 66%
• Classical Phenotype 33%
• Classical Variant 33%
• Clinical Trials 33%
• Disease Manifestations 33%
• Enzyme Replacement Therapy 100%
• Fabry Disease 100%
• GL(3) 100%
• Globotriaosylceramide 33%
• Glycosphingolipids 33%
• Hypohidrosis 33%
• Increasing Age 33%
• Interstitial Cells 33%
• Lenticular 33%
• Lysosomal Storage Disease 33%
• Mesangial Cells 33%
• Nephropathy 100%
• Opacity 33%
• Podocyte 33%
• Proteinuria 66%
• Recombinant 33%
• Renal Failure 66%
• Renal Insufficiency 33%
• Renal Involvement 33%
• Renal Pathology 33%
• Renal Variant 66%
• Variant Genotype 33%
• Vascular Endothelial Cells 33%
• X-linked 33%
• β-Galactosidase (β-Gal) 33%

Medicine and Dentistry

• Adolescence 33%
• Angiokeratoma 33%
• Anhidrosis 33%
• Cataract 33%
• Clinical Trial 33%
• Diseases 33%
• Endothelial Cell 33%
• Enzyme Replacement Therapy 100%
• Enzymes 33%
• Fabry Disease 100%
• Galactose 33%
• Galactosidase 33%
• Globotriaosylceramide 33%
• Glycosphingolipid 33%
• Interstitial Cell 33%
• Lifespan 33%
• Lysosomal Storage Disease 33%
• Mesangial Cell 33%
• Nephropathy 100%
• Podocyte 33%
• Proteinuria 66%
• Renal Failure 100%